William John Scheessele, Chief Commercial Officer at Humacyte, Inc. (HUMA), bought 6,493 shares at $1.54 ($10K) on 2025-04-14, disclosed to the SEC on 2025-04-15.
Open-market purchase of $10k HUMA by Chief Commercial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |